A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4174 (2006.01) A61K 45/06 (2006.01) A61P 31/04 (2006.01)
Patent
CA 2669594
There is described clotrimazole, l-[(2-chlorophenyl) diphenylmethyl]-lH-imidazole (C22H17ClN2); and derivatives thereof, for the treatment of an infection caused by or contributed to a methicillin resistant Staphylococcus species. There is also described a method of treating a patient suffering from an infection caused by or contributed to a methicillin resistant Staphylococcus species, said method comprising the step of administering an effective amount of clotrimazole, and derivatives thereof.
L'invention concerne du clotrimazole, l-[(2-chlorophényle) diphénylméthyle]-lH-imidazole (C22H17ClN2) ; et leurs dérivés. Ces substances sont destinées au traitement d'une infection causée ou contribuées par des espèces Staphylococcus résistantes à la méthicilline. L'invention concerne également un procédé permettant de traiter un patient souffrant d'une infection causée ou contribuées par des espèces Staphylococcus résistantes à la méthicilline, ledit procédé comprenant l'étape qui consiste à administrer une dose efficace de clotrimazole, et de ses dérivés.
Charlton Julie Anne
Idowu Olosola Clement
Yates Catherine Mary
Young Malcolm Philip
Charlton Julie Anne
E-Therapeutics Limited
Idowu Olosola Clement
Norton Rose Canada S.e.n.c.r.l.,s.r.l./llp
Yates Catherine Mary
LandOfFree
Clotrimazol for treating staphylococcal infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Clotrimazol for treating staphylococcal infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clotrimazol for treating staphylococcal infections will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1617017